These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22465126)

  • 1. Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay.
    Apple FS; Smith SW; Pearce LA; Murakami MM
    Clin Biochem; 2012 Jul; 45(10-11):711-3. PubMed ID: 22465126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the bioMérieux VIDAS troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.
    Apple FS; Smith SW; Pearce LA; Ler R; Murakami MM; Benoit MO; Levy C; Dumas C; Paul JL
    Clin Chim Acta; 2008 Apr; 390(1-2):72-5. PubMed ID: 18230357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.
    Apple FS; Smith SW; Pearce LA; Ler R; Murakami MM
    Clin Chem; 2008 Apr; 54(4):723-8. PubMed ID: 18238833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.
    Bonaca M; Scirica B; Sabatine M; Dalby A; Spinar J; Murphy SA; Jarolim P; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2010 May; 55(19):2118-24. PubMed ID: 20447535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events.
    Apple FS; Pearce LA; Smith SW; Kaczmarek JM; Murakami MM
    Clin Chem; 2009 May; 55(5):930-7. PubMed ID: 19299542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays.
    Reiter M; Twerenbold R; Reichlin T; Haaf P; Peter F; Meissner J; Hochholzer W; Stelzig C; Freese M; Heinisch C; Breidthardt T; Freidank H; Winkler K; Campodarve I; Gea J; Mueller C
    Eur Heart J; 2011 Jun; 32(11):1379-89. PubMed ID: 21362702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction.
    Keller T; Zeller T; Ojeda F; Tzikas S; Lillpopp L; Sinning C; Wild P; Genth-Zotz S; Warnholtz A; Giannitsis E; Möckel M; Bickel C; Peetz D; Lackner K; Baldus S; Münzel T; Blankenberg S
    JAMA; 2011 Dec; 306(24):2684-93. PubMed ID: 22203537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of the Ortho Vitros cardiac troponin I assay in patients with symptoms of myocardial ischemia. Risk stratification using European Society of Cardiology/American College of Cardiology recommended cutoff values.
    Apple FS; Murakami MM; Quist HH; Pearce LA; Wieczorek S; Wu AH
    Am J Clin Pathol; 2003 Jul; 120(1):114-20. PubMed ID: 12866381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term (90 min) diagnostic performance for acute non-ST segment elevation myocardial infarction and 30-day prognostic evaluation of a novel third-generation high sensitivity troponin I assay.
    Schreiber DH; Agbo C; Wu AH
    Clin Biochem; 2012 Nov; 45(16-17):1295-301. PubMed ID: 22705845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays.
    Reiter M; Twerenbold R; Reichlin T; Benz B; Haaf P; Meissner J; Hochholzer W; Stelzig C; Freese M; Heinisch C; Balmelli C; Drexler B; Freidank H; Winkler K; Campodarve I; Gea J; Mueller C
    Eur Heart J; 2012 Apr; 33(8):988-97. PubMed ID: 22044927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic role of cardiac troponin I (cTnI) measured on the DPC Immulite.
    Collinson PO; Gaze DC; Stubbs PJ; Swinburn J; Khan M; Senior R; Lahiri A
    Clin Biochem; 2006 Jul; 39(7):692-6. PubMed ID: 16580659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic performance of kinetic changes of high-sensitivity troponin T in acute coronary syndrome and in patients with increased troponin without acute coronary syndrome.
    Mueller M; Biener M; Vafaie M; Blankenberg S; White HD; Katus HA; Giannitsis E
    Int J Cardiol; 2014 Jul; 174(3):524-9. PubMed ID: 24814895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta troponin for the early diagnosis of AMI in emergency patients with chest pain.
    Cullen L; Parsonage WA; Greenslade J; Lamanna A; Hammett CJ; Than M; Tate J; Kalinowski L; Ungerer JP; Chu K; Brown A
    Int J Cardiol; 2013 Oct; 168(3):2602-8. PubMed ID: 23582689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the Advia Centaur second-generation troponin assay TnI-Ultra compared with the first-generation cTnI assay.
    van de Kerkhof D; Peters B; Scharnhorst V
    Ann Clin Biochem; 2008 May; 45(Pt 3):316-7. PubMed ID: 18482922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
    Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.
    Venge P; Johnston N; Lindahl B; James S
    J Am Coll Cardiol; 2009 Sep; 54(13):1165-72. PubMed ID: 19761938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What does elevated high-sensitive troponin I in stroke patients mean: concomitant acute myocardial infarction or a marker for high-risk patients?
    Anders B; Alonso A; Artemis D; Schäfer A; Ebert A; Kablau M; Fluechter S; Findeisen P; Hennerici MG; Fatar M
    Cerebrovasc Dis; 2013; 36(3):211-7. PubMed ID: 24135532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.
    Viswanathan K; Kilcullen N; Morrell C; Thistlethwaite SJ; Sivananthan MU; Hassan TB; Barth JH; Hall AS
    J Am Coll Cardiol; 2010 Jun; 55(23):2590-8. PubMed ID: 20513600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay.
    Apple FS; Simpson PA; Murakami MM
    Clin Biochem; 2010 Aug; 43(12):1034-6. PubMed ID: 20510894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two clinical scoring systems in risk stratification of non-ST elevation acute coronary syndrome patients in predicting 30-day outcomes.
    Rawlings C; Oglesby K; Turner J; Sen A
    Emerg Med J; 2012 Jan; 29(1):40-2. PubMed ID: 21233485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.